Order Now, Ships Today
One-time
| Quantity | Discount | Discounted price |
| 3 - 4 | 5% | - |
| 5 - 6 | 7% | - |
| 7 - 8 | 9% | - |
| 9 + | 11% | - |
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
Sermorelin (GRF 1–29) is a synthetic analog of growth hormone–releasing hormone (GHRH), designed to stimulate the natural release of GH through pituitary receptor signaling. It has been studied as a shorter-acting GHRH fragment that promotes the secretion of endogenous GH in controlled models, helping researchers explore the biological pathways involved in growth hormone regulation, metabolism, and tissue recovery.
This research peptide is verified for 99%+ purity. COA: Sermorelin (5mg / 10mg)
Products from Elite Miami Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
Each vial contains exactly what’s indicated on the label. For instance, a 10mg vial contains precisely 10mg of lyophilized peptide. Researchers may divide it into smaller research portions—such as four 2.5mg aliquots—but the total content remains the same.
Yes. All peptides are supplied in lyophilized powder form and do not come reconstituted. Any extra materials required for research, such as solvents or diluents, must be obtained separately.
When stored as a dry powder, peptides remain stable for up to 2 years.
Once reconstituted, the solution should be kept refrigerated and is typically stable for up to 2 months under proper storage conditions.
Sermorelin represents the first 29 amino acids of the naturally occurring GHRH peptide — the sequence responsible for directly stimulating GH release from the anterior pituitary gland. Because it closely mirrors the body’s natural GH release process, Sermorelin has been widely studied as a model compound to understand pituitary signaling and GH pulse patterns in endocrine research.
Sermorelin is a shortened version of the natural hormone that signals the body to release growth hormone. Because it works like the body’s own process, researchers use it to study how GH is released and regulated.
⚠️ Disclaimer: this product is not approved for medical use and is not intended to diagnose, treat, or prevent any disease. All information provided is for educational and research purposes only, and this product must never be used in humans or animals.
Sermorelin was developed in the late 20th century as a stabilized fragment of GHRH (1-29), the biologically active portion of the endogenous hormone. Initial investigations focused on its pharmacokinetics and ability to promote pituitary GH release. Since then, it has been used widely in experimental models to study endocrine dynamics, tissue recovery, and age-related changes in growth hormone signaling. Walker R.F., Risher W.H. et al. (1994).
CAS #: 86168-78-7 Molecular Formula: C₁₄₉H₂₄₆N₄₄O₄₂S Molecular Weight: 3357.9 g/mol PubChem ID: 16132308
Sermorelin has been explored in numerous laboratory studies related to growth hormone release, pituitary response, and metabolic regulation. Key research areas include: Endocrine: natural GH pulse stimulation and receptor activity. Metabolic: lipid metabolism, glucose utilization, protein synthesis. Cellular: pituitary cell signaling and GH-releasing hormone cascade. Recovery: repair and regeneration through GH-axis activation. Findings support Sermorelin’s role as a short-acting GH secretagogue model for understanding hormonal feedback mechanisms.
In simple terms, Sermorelin is used in research to help scientists understand how the body naturally produces and releases growth hormone. It acts as a signal to the pituitary gland, prompting GH release in short, natural bursts. It’s important to remember that Sermorelin is for research use only and must not be used in humans or animals under any circumstances.
Walker R.F., et al. (2015). Pituitary GHRH analog studies with GRF 1–29 fragments. Bowers C.Y., et al. (1999). Characterization of Sermorelin and short GHRH analogs in GH release models. Laron Z., et al. (2002). Endocrine modulation through GHRH receptor analogs. Hulse G., et al. (2018). Comparative evaluation of Sermorelin and modified GHRH peptides.
Sep 25, 2025
By far the best in the market! Good prices, transparent transaction no games! Most importantly extremely responsive! So if you’re looking for products that work this is your site!
Aug 20, 2025
The service and products from Elite Miami Peptides are amazing. I was turned on to the company by several of my peers and I ordered some peptides. Not only was the delivery fast, but I was also able to save money. I will be using Elite Miami Peptides again for ALL my peptide needs.
Sep 25, 2025
Great products, super fast shipping and so helpful. Always a great experience dealing with Elite Miami Peptides. I highly recommend EMP - these guys are great!
Aug 24, 2025
Gave me exactly what I wanted. The service and response was good. I have ordered from them before and will continue.
Our specialists respond within minutes to any order or product inquiry.
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
By clicking the button above, you agree to receive marketing text messages from Elite Miami Peptides at the number provided. Consent is not a condition of purchase. Msg & data rates may apply. Reply STOP to cancel, HELP for help. View our Privacy Policy.
All compounds from Elite Miami Peptides are intended strictly for laboratory research purposes.
They are not for human use, consumption, or therapeutic applications.
Products are supplied exclusively to qualified professionals working in compliance with all applicable laws and regulations.
